US 11801296
Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R
granted A61KA61K2039/5254A61K2039/552
Quick answer
US patent 11801296 (Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/5254, A61K2039/552, A61K39/12, A61P